Retrieve available abstracts of 208 articles: HTML format
Single Articles
July 2025
SAGNAK YILMAZ Z, Demir Kececi S, Aydin Mungan S, Saygin I, et al Comparison of somatic mutations and clinicopathologic features of micropapillary
and non-micropapillary colorectal carcinomas.
BMC Cancer. 2025;25:1100. PubMedAbstract available
HUANG J, Xu L, Cai Y, Tan X, et al Certain pMMR colorectal cancer patients should undergo additional MSI-PCR testing
to reduce the risk of misdiagnosing MSI-H and Lynch syndrome.
BMC Cancer. 2025;25:1103. PubMedAbstract available
LI N, Gao LJ, Guo KX, Wang J, et al NHP2 and PRPF4 are hub genes associated with the prognosis of colorectal cancer.
BMC Cancer. 2025;25:1088. PubMedAbstract available
WANG W, Zhou Z, Cheng X, Chen L, et al Preimplantation genetic testing for monogenic disorders to prevent MSH6 germline
pathogenic variant related colorectal cancer.
BMC Cancer. 2025;25:1131. PubMedAbstract available
ANSAB M, Razi S, Nisa F, Araib E, et al Neoadjuvant chemoradiotherapy with or without PD-1/PD-L1 inhibitors in locally
advanced rectal cancer: a systematic review and meta-analysis.
BMC Cancer. 2025;25:1084. PubMedAbstract available
RUSS E, Ziemons J, Hillege LE, van Kuijk SMJ, et al Evaluation of potential biomarkers during irinotecan-based systemic treatment for
colorectal cancer-study protocol of the OPTIMA study.
BMC Cancer. 2025;25:1129. PubMedAbstract available
June 2025
TISELIUS C, Johansen F, Rosenblad A, Smedh K, et al Health-related quality of life is a significant prognostic factor for recurrence
and overall survival in patients with colon cancer.
BMC Cancer. 2025;25:1016. PubMedAbstract available
WANG Y, Lu J, Huang D, Chen P, et al Explosive tumor growth in a patient with colon cancer is associated with reduced
neoantigen levels and decreased interferon-gamma (IFN-gamma) signaling.
BMC Cancer. 2025;25:1005. PubMedAbstract available
MA A, Zhai C, He Q, Wang W, et al ENTR1 affects the progression of colon cancer by regulating energy metabolism
under the influence of glycolysis.
BMC Cancer. 2025;25:992. PubMedAbstract available
SABERPOUR M, Maqsoodi R, Bakhshi B Anti-cancer properties of chitosan /Lactobacillus acidophilus secretome
nanoparticle on signaling pathways of colorectal cancer in colon adenocarcinoma
(Caco-2) cell line.
BMC Cancer. 2025;25:983. PubMedAbstract available
ZENG Z, Ke Y, Huang F, Li H, et al Targeting INF2 with DiosMetin 7-O-beta-D-Glucuronide: a new stratagem for colorectal
cancer therapy.
BMC Cancer. 2025;25:982. PubMedAbstract available
XIE X, Wang W, Zhang H, Zhao S, et al Cholesterol-induced colorectal cancer progression and its mitigation through gut
microbiota remodeling and simvastatin treatment.
BMC Cancer. 2025;25:977. PubMedAbstract available
May 2025
VAHED IE, Moshgelgosha M, Kor A, Minadi M, et al The role of Adiponectin and Leptin in Colorectal Cancer and Adenoma: a systematic
review and meta-analysis.
BMC Cancer. 2025;25:968. PubMedAbstract available
PHAM HT, Nguyen TA, Ba TL, Tran VNM, et al Quality of life in patients with metastatic colorectal cancer receiving cytotoxic
and cytotoxic plus targeted therapy.
BMC Cancer. 2025;25:957. PubMedAbstract available
JEON Y, Jung M, Jeong B, Lee H, et al Phase I study of the safety, tolerability, and potential therapeutic dose of
OMT-110 for patients with refractory metastatic Colorectal Cancer.
BMC Cancer. 2025;25:937. PubMedAbstract available
SHIRZAD S, Eterafi M, Karimi Z, Barazesh M, et al MicroRNAs involved in colorectal cancer, a rapid mini-systematic review.
BMC Cancer. 2025;25:934. PubMedAbstract available
LJUNGGREN M, Dietrich CE, Rosander E, Palmer G, et al Correction: Hospital factors and metastatic surgery in colorectal cancer
patients, a population-based cohort study.
BMC Cancer. 2025;25:929. PubMed
ZHANG X, Zhang J, Zhao C, Cai Y, et al Effects of individualized PEEP on pulmonary function, cerebral blood flow and
postoperative cognitive function in patients undergoing laparoscopic radical
resection of rectal cancer.
BMC Cancer. 2025;25:927. PubMedAbstract available
CASTANEDA-AVILA MA, Latoni-Guillermety D, Sabatino M, Ortiz-Ortiz KJ, et al Challenges oncologists face when caring for hispanics living in puerto rico with
colorectal cancer and multiple chronic conditions.
BMC Cancer. 2025;25:898. PubMedAbstract available
ASEFI M, Rezvani N, Saidijam M, Soltanian AR, et al Evaluation of epigenetic silencing of the miR-139-5p gene in the pathogenesis of
colorectal cancer and its diagnostic biomarker capability in plasma samples.
BMC Cancer. 2025;25:877. PubMedAbstract available
SAMUELSSON M, Edman K, Neziraj M, Ericsson A, et al Aiming for survival: a qualitative single case study of support for family
members across the care process in outpatient colorectal cancer care.
BMC Cancer. 2025;25:856. PubMedAbstract available
ZHANG X, Zhao T, Wu C, Shen H, et al LncRNA CASC19 promotes the growth and glycolysis of colorectal cancer cells and
tumor metastasis in mice.
BMC Cancer. 2025;25:829. PubMedAbstract available
April 2025
LI W, Liu B, Xiang X, Zhang Q, et al Lymphovascular invasion affects prognosis of colorectal cancer liver metastasis
underwent primary resection: a propensity score matching analysis.
BMC Cancer. 2025;25:793. PubMedAbstract available
WISMAYER R, Matthews R, Whalley C, Kiwanuka J, et al The role of MLH1, MSH2 and MSH6 in the development of colorectal cancer in
Uganda.
BMC Cancer. 2025;25:792. PubMedAbstract available
CHIGVINADZE N, Pantsulaia I, Lejava T, Aladashvili A, et al Suppressor protein plasma levels and inflammatory indices in colorectal cancer
patients.
BMC Cancer. 2025;25:774. PubMedAbstract available
LU L, Li H, Yin H, Wang F, et al The expression of PRMT5 is associated with postoperative chemotherapeutic outcome
in colon cancer.
BMC Cancer. 2025;25:760. PubMedAbstract available
MENG B, Ma Y, Wang Y, Zhou M, et al Dual-Time-Point (18)F-FDG PET/CT imaging in the diagnosis of colorectal carcinoma
or advanced adenoma in patients with fixed focal colorectal (18)F-FDG uptake.
BMC Cancer. 2025;25:755. PubMedAbstract available
GEBRELIBANOS H, Taye G, Wondimagegnehu A, Feyisa JD, et al The quality of life of colorectal cancer patients attending the cancer center in
addis Ababa, Ethiopia.
BMC Cancer. 2025;25:754. PubMedAbstract available
LI S, Wang H, Xu XQ, Li WM, et al Association of pre-diagnosis plasma proteomic contexture with overall survival of
early- and late-stage colon cancer patients.
BMC Cancer. 2025;25:744. PubMedAbstract available
VALLADARES-AYERBES M, Toledano-Fonseca M, Grana B, Jimenez-Fonseca P, et al Associations of blood RNA biomarkers and circulating tumour cells in patients
with previously untreated metastatic colorectal cancer.
BMC Cancer. 2025;25:743. PubMedAbstract available
WANG S, Jin X, Ba Y, Liu W, et al Differentiating rectal cancer grades using virtual magnetic resonance
elastography and fractional order calculus diffusion model.
BMC Cancer. 2025;25:734. PubMedAbstract available
HAYASHI M, Nakamura K, Harada S, Tanaka M, et al GLUT1 inhibition by BAY-876 induces metabolic changes and cell death in human
colorectal cancer cells.
BMC Cancer. 2025;25:716. PubMedAbstract available
GAO Y, Hu P, Wu N, Tan F, et al A study protocol for the CHinA National CancEr screening (CHANCES) trial: a
randomized controlled study to compare the screening strategies for lung cancer
and colorectal cancer.
BMC Cancer. 2025;25:727. PubMedAbstract available
XUE JS, Maimaitiming N, Zhang BL, Xu BW, et al Prognostic analysis of patients with CRLM based on CRS score: a single-center
retrospective study.
BMC Cancer. 2025;25:718. PubMedAbstract available
QIU Z, Cheng Y, Liu H, Li T, et al Screening colorectal cancer associated autoantigens through multi-omics analysis
and diagnostic performance evaluation of corresponding autoantibodies.
BMC Cancer. 2025;25:713. PubMedAbstract available
LI R, Sun X, Yu Z, Li P, et al Identification of predictors for lymph node metastasis in T2 colorectal cancer:
retrospective cohort study from a high-volume hospital.
BMC Cancer. 2025;25:700. PubMedAbstract available
ZHENG QQ, Lin WF Inhibition of miR-325 inhibits KIF20B expression and the colorectal cancer cells'
invasion & proliferation.
BMC Cancer. 2025;25:680. PubMedAbstract available
HAGHIGHI L, Dalimi A, Pirestani M, Ghaffarifar F, et al The effect of Entamoeba histolytica lectin antigen and microRNA-643 on the
development of microsatellite instability (MSI) in colorectal adenocarcinoma.
BMC Cancer. 2025;25:663. PubMedAbstract available
CUI Y, Mei J, Zhao S, Zhu B, et al Identification of a PANoptosis-related long noncoding rna risk signature for
prognosis and immunology in colon adenocarcinoma.
BMC Cancer. 2025;25:662. PubMedAbstract available
AROLDI F, Elez E, Andre T, Perkins G, et al A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib
in patients with RAS mutant advanced colorectal cancer (MErCuRIC).
BMC Cancer. 2025;25:658. PubMedAbstract available
LIU T, Jiao S, Gao S, Shi Y, et al Optimal lymph node yield for long-term survival in elderly patients with
right-sided colon cancer: a large population-based cohort study.
BMC Cancer. 2025;25:590. PubMedAbstract available
HAUAN M, Rylander C, Skeie G Sweet beverages and the risk of colorectal cancer: the Norwegian Women and Cancer
Study.
BMC Cancer. 2025;25:592. PubMedAbstract available
SAM I, Dang W, Iu N, Luo Z, et al Barriers and facilitators to anal cancer screening among men who have sex with
men: a systematic review with narrative synthesis.
BMC Cancer. 2025;25:586. PubMedAbstract available
March 2025
ZHU Z, Jiang D, Jiang Y, Quan J, et al Dentate line invasion is a risk factor for locoregional recurrence and distant
metastasis following abdominoperineal resection in rectal cancer: a single-centre
retrospective cohort study based on 1854 cases.
BMC Cancer. 2025;25:574. PubMedAbstract available
FU C, Fu J, Liu C, Yu Z, et al Synergistic potential of CDH3 in targeting CRC metastasis and enhancing
immunotherapy.
BMC Cancer. 2025;25:560. PubMedAbstract available
SHAHABI F, Abdollahi A, Zarif-Sadeghian M, Ziyaie D, et al Rectal prolapse as an initial presentation of colorectal cancer: a systematic
review.
BMC Cancer. 2025;25:553. PubMedAbstract available
BOUDNA M, Blavet N, Samoilenko T, Machackova T, et al Analysis of extracellular vesicles of frequently used colorectal cancer cell
lines.
BMC Cancer. 2025;25:555. PubMedAbstract available
WANG X, Wang Y, Chen Z, Zheng Z, et al Proficient surgeons enhance conversion rates and sphincter preservation in
robotic rectal cancer surgery with comparable long-term outcomes: a comparative
study with laparoscopy in a large-volume center in China.
BMC Cancer. 2025;25:545. PubMedAbstract available
WU Y, Qu Z, Wu Z, Zhuang J, et al Multiple primary malignancies and gut microbiome.
BMC Cancer. 2025;25:516. PubMedAbstract available
LONG C, Cheng J, Feng M, Yan B, et al Association of the tumor microenvironment collagen score and immunoscore with
colon cancer lymph node metastasis.
BMC Cancer. 2025;25:506. PubMedAbstract available
WANG J, Gong Z, Liu J, Wang W, et al Fc fragment of IgG binding protein suppresses tumor growth by stabilizing wild
type P53 in colorectal cancer cells.
BMC Cancer. 2025;25:507. PubMedAbstract available
WANG Y, Yang Z, Li Z, Huang L, et al Proteomics-driven discovery of LCAT as a novel biomarker for liver metastasis in
colorectal cancer.
BMC Cancer. 2025;25:480. PubMedAbstract available
NOURBAKHSH ST, Mirzaei SA, Mohamadhashem F, Naghizadeh MM, et al Pathological expression of mitochondrial genome-derived circRNA SCAR/mc-COX2 and
its ceRNA network in colorectal cancer: implications for clinical significance.
BMC Cancer. 2025;25:466. PubMedAbstract available
ZHANG J, Dong B, Dong H, Guo D, et al Gender-specific differences in factors influencing supportive care needs in
colorectal cancer patients.
BMC Cancer. 2025;25:471. PubMedAbstract available
YUN D, Yang JH, Yang S, Sim JA, et al Novel genetic loci and functional properties of immune-related genes for
colorectal cancer survival in Korea.
BMC Cancer. 2025;25:456. PubMedAbstract available
HOFSLI E, Saetrom P, Ness-Jensen E, Surcel HM, et al Can circulating microRNAs predict colorectal cancer? Results from a nested
case-control study of pre-diagnostic serum samples from two prospective biobanks.
BMC Cancer. 2025;25:455. PubMedAbstract available
YANG M, Nebozhyn MV, Schell MJ, Gandhi N, et al Identifying distinct prognostic and predictive contributions of tumor epithelium
versus tumor microenvironment in colorectal cancer.
BMC Cancer. 2025;25:441. PubMedAbstract available
WANG Y, Jia R, Si H, Ma Y, et al Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line
treatment for patients with RAS-mutant, microsatellite stable, metastatic
colorectal cancer.
BMC Cancer. 2025;25:422. PubMedAbstract available
LI Z, Feng C, Liu H, Liu Y, et al Factors influencing clinical decision-making and health-related quality of life
changes in colorectal cancer patients receiving targeted therapy: a multicenter
study in China.
BMC Cancer. 2025;25:423. PubMedAbstract available
POWER S, Wooldrage K, Thomas-Gibson S, Cross AJ, et al The impact of patient-reported factors of endoscopic screening experience on
attendance at future examinations and distal colorectal cancer incidence.
BMC Cancer. 2025;25:409. PubMedAbstract available
ALMILAJI O, Sharples L, Aggarwal A, Cromwell D, et al Value of hospital administrative data linked to national cancer registry records
to identify metastatic disease at time of primary diagnosis in colorectal cancer
patients: a study using national data in England.
BMC Cancer. 2025;25:407. PubMedAbstract available
CHEN C, Fu Q, Wang L, Tanaka S, et al Establishment of a novel mouse model of colorectal cancer by orthotopic
transplantation.
BMC Cancer. 2025;25:405. PubMedAbstract available
LI H, Sun W, Fu S, Wang J, et al Prognostic value of the preoperative prognostic nutritional and systemic
immunoinflammatory indexes in patients with colorectal cancer.
BMC Cancer. 2025;25:403. PubMedAbstract available
LI Y, Zhuang M, Mei S, Hu G, et al Gut microbiota, immune cell, colorectal cancer association mediators: a Mendelian
randomization study.
BMC Cancer. 2025;25:396. PubMedAbstract available
NAVARRO-SANCHEZ A, Nieto-Vitoria MA, Lopez-Lopez JA, Martinez-Crespo JJ, et al Is the oral pathogen, Porphyromona gingivalis, associated to colorectal cancer?:
a systematic review.
BMC Cancer. 2025;25:395. PubMedAbstract available
LIU R, Tang L, Liu Y, Hu H, et al Causal relationship between immune cell signatures and colorectal cancer: a
bi-directional, two-sample mendelian randomization study.
BMC Cancer. 2025;25:387. PubMedAbstract available
February 2025
LENG W, Wen Z, Wang H, Cao P, et al Raltitrexed, S-1 and fruquintinib (RSF) in the treatment of refractory metastatic
colorectal cancer: study protocol for a multicenter, prospective, single-arm,
phase II trial.
BMC Cancer. 2025;25:376. PubMedAbstract available
GAO F, Zhang Q, Teng F, Li L, et al Assessing the causal association between 731 immunophenotypes and the risk
of colorectal cancer: a Mendelian randomization study.
BMC Cancer. 2025;25:335. PubMedAbstract available
PONVILAWAN B, Sakornsakolpat P, Pongpaibul A, Roothumnong E, et al Comprehensive genomic analysis in sporadic early-onset colorectal adenocarcinoma
patients.
BMC Cancer. 2025;25:349. PubMedAbstract available
AZEEM M, Ur Rehman A, Rasheed S, Shahzad A, et al The impact of combining cetuximab with the traditional chemotherapy regimens on
clinical effectiveness in metastatic colorectal cancer: a systematic review and
meta-analysis.
BMC Cancer. 2025;25:331. PubMedAbstract available
FENG R, Li X, Li B, Luan T, et al Integrating transcriptomics and scPagwas analysis predicts naive CD4 T
cell-related gene DRAM2 as a potential biomarker and therapeutic target for
colorectal cancer.
BMC Cancer. 2025;25:317. PubMedAbstract available
KOCH PF, Ludwig K, Hillebrandt KH, Freitag H, et al Gender-based variations in surgical management of colorectal liver metastases:
comprehensive analysis.
BMC Cancer. 2025;25:315. PubMedAbstract available
LI L, Zhang R, Li Y Up-regulation of m(6)A writer METTL14 inhibits tumorigenesis by suppressing
glycolysis in colorectal cancer.
BMC Cancer. 2025;25:305. PubMedAbstract available
ZHU J, Gao Y, Zhang C, Wu Y, et al Prognostic significance of preoperative CT-based sarcopenia in locally advanced
rectal cancer: a multicenter retrospective study.
BMC Cancer. 2025;25:261. PubMedAbstract available
LI Z, Aihemaiti Y, Yang Q, Ahemai Y, et al Survival machine learning model of T1 colorectal postoperative recurrence after
endoscopic resection and surgical operation: a retrospective cohort study.
BMC Cancer. 2025;25:262. PubMedAbstract available
CHEN J, Hu Q, Zhang C, Zhao A, et al Tendomodulin in pan-cancer analysis: exploring its impact on immune modulation
and uncovering functional insights in colorectal cancer.
BMC Cancer. 2025;25:239. PubMedAbstract available
ZHANG X, Xu Z, Shang L, Yang Q, et al Global burden of colorectal cancer attributable to metabolic risks from 1990 to
2021, with predictions to 2046.
BMC Cancer. 2025;25:228. PubMedAbstract available
LEE JG, Park I, Lee H, Nam S, et al Correction: Integrating E-cadherin expression levels with TNM staging for
enhanced prognostic prediction in colorectal cancer patients.
BMC Cancer. 2025;25:214. PubMed
KYE BH, Kim JH, Kim HJ, Lee YS, et al Oncologic oUTcomes of neoadjuvant chemotherapy for obSTructive colon cAncer after
steNt decompression (OUTSTAND trial); A study protocol of multicenter
non-inferiority randomized controlled trial.
BMC Cancer. 2025;25:194. PubMedAbstract available
LIU ZM, Yao QJ, Pei F, He F, et al Efficacy and safety of reduced-port laparoscopic surgery versus conventional
laparoscopic surgery for colorectal cancer.
BMC Cancer. 2025;25:187. PubMedAbstract available
January 2025
YE M, Xu G, Zhang L, Kong Z, et al Meta Analysis of Methylenetetrahydrofolate Reductase (MTHFR) C677T polymorphism
and its association with folate and colorectal cancer.
BMC Cancer. 2025;25:169. PubMedAbstract available
BAGREZAEI F, Gargari BP, Zamiri RE, Safaiyan A, et al Assessment of the quality of life in metastatic colorectal cancer patients with
KRAS gene mutant: a case-control study.
BMC Cancer. 2025;25:158. PubMedAbstract available
LEE JG, Park I, Lee H, Nam S, et al Integrating E-cadherin expression levels with TNM staging for enhanced prognostic
prediction in colorectal cancer patients.
BMC Cancer. 2025;25:150. PubMedAbstract available
HOU Z, Qin N, He Y, Chen J, et al Association between colorectal cancer and arthritis among Americans in 2005-2016.
BMC Cancer. 2025;25:140. PubMedAbstract available
YONEZAWA A, Shimomura K, Okamoto K, Takeda H, et al Inhibition of BRD4 attenuated IFNgamma-induced apoptosis in colorectal cancer
organoids.
BMC Cancer. 2025;25:136. PubMedAbstract available
WALLE GT, Kitaw TA, Adane S Incidence and determinants of mortality among patients with colorectal cancer in
oncology centers of Amhara region, Ethiopia, 2024: multicenter retrospective
follow up study.
BMC Cancer. 2025;25:102. PubMedAbstract available
NISHI M, Yamashita S, Takasu C, Wada Y, et al Role of mast cell in locally advanced rectal cancer treated with neoadjuvant
chemoradiotherapy.
BMC Cancer. 2025;25:99. PubMedAbstract available
SHEN J, Gong X, Ren H, Tang X, et al Identification and validation of CDK1 as a promising therapeutic target for
Eriocitrin in colorectal cancer: a combined bioinformatics and experimental
approach.
BMC Cancer. 2025;25:76. PubMedAbstract available
BOVELL AAN, Ramaliba T, Goodwin SO, Phillip JC, et al Incidence, trends and patterns of female breast, cervical, colorectal and
prostate cancers in Antigua and Barbuda, 2017-2021: a retrospective study.
BMC Cancer. 2025;25:72. PubMedAbstract available
ZHAO Y, Xun D, Chen J, Qi X, et al A novel machine learning-based immune prognostic signature for improving clinical
outcomes and guiding therapy in colorectal cancer: an integrated bioinformatics
and experimental study.
BMC Cancer. 2025;25:65. PubMedAbstract available
DELI H, Vakili-Ghartavol Z, Asgari Y, Tavoosidana G, et al The expression of exosomal and cellular miRNAs in predicting oxaliplatin
resistance in colorectal cancer cells: an in silico and in vitro study.
BMC Cancer. 2025;25:46. PubMedAbstract available
EVERATT R, Kuzmickiene I, Brasiuniene B, Vincerzevskiene I, et al Postdiagnostic use of antihypertensive medications and survival in colorectal,
lung, corpus uteri, melanoma and kidney cancer patients with hypertension.
BMC Cancer. 2025;25:38. PubMedAbstract available
CHEN D, Ma Y, Li J, Wen L, et al Causality between insulin use and malignant tumors of the digestive system: a
two-sample mendelian randomized study.
BMC Cancer. 2025;25:31. PubMedAbstract available
YANG J, Cao Z, Yu C, Cui W, et al Identification of a mitophagy-related gene signature for predicting overall
survival and response to immunotherapy in rectal cancer.
BMC Cancer. 2025;25:15. PubMedAbstract available
TAKAHASHI T, Shigeyasu K, Kondo Y, Takeda S, et al Predictive marker for response to trifluridine/tipiracil plus bevacizumab in
metastatic colorectal cancer patients.
BMC Cancer. 2025;25:1. PubMedAbstract available
December 2024
WANG Z, Han W, Fei R, Hu Y, et al Age, frequency, and strategy optimization for organized colorectal cancer
screening: a decision analysis conducted in China for the years 2023-2038.
BMC Cancer. 2024;24:1596. PubMedAbstract available
ZHANG Y, Huang Y, Xu M, Zhuang J, et al Pathomics-based machine learning models for predicting pathological complete
response and prognosis in locally advanced rectal cancer patients
post-neoadjuvant chemoradiotherapy: insights from two independent institutional
studies.
BMC Cancer. 2024;24:1580. PubMedAbstract available
DANG W, Wu S, Liu X, Shen H, et al Association between quantitative CT body composition analysis and prognosis in
cetuximab-based first-line treatment for advanced colorectal cancer patients.
BMC Cancer. 2024;24:1579. PubMedAbstract available
ZHOU X, Dai J, Lu Y, Zhao Q, et al Whole slide image based prognosis prediction in rectal cancer using unsupervised
artificial intelligence.
BMC Cancer. 2024;24:1523. PubMedAbstract available
LIANG L, Xu N, Ding L, Li X, et al Combined inflammation-related biomarkers and clinicopathological features for the
prognosis of stage II/III colorectal cancer by machine learning.
BMC Cancer. 2024;24:1548. PubMedAbstract available
TAKASU C, Morine Y, Yoshikawa K, Tokunaga T, et al Impact of pure desmoplastic histological growth patterns in colorectal liver
metastasis.
BMC Cancer. 2024;24:1528. PubMedAbstract available
LI H, Chen J, Liu Z, Pan L, et al Construction of a novel copper-induced-cell-death-related gene signature for
prognosis in colon cancer, with focus on KIF7.
BMC Cancer. 2024;24:1532. PubMedAbstract available
DOS REIS MB, Dos Santos W, de Carvalho AC, Lima AB, et al Plasma mutation profile of precursor lesions and colorectal cancer using the
Oncomine Colon cfDNA Assay.
BMC Cancer. 2024;24:1547. PubMedAbstract available
November 2024
LIU C, Xie J, Ye B, Zhong J, et al Unraveling the link between sterol ester and colorectal cancer: a two-sample
mendelian randomization study.
BMC Cancer. 2024;24:1462. PubMedAbstract available
LI M, Li Z, Wu X, Yubo Pan, et al Exploring the correlation between Tom1L1 and the efficacy of neoadjuvant
chemotherapy for locally progressive mid-low rectal cancer.
BMC Cancer. 2024;24:1413. PubMedAbstract available
CHEN Z, Cao H, Zhang J, Zhong W, et al The impact of preoperative treatment on mismatch repair protein and HER2
expression in colorectal cancer: an analysis of paired samples.
BMC Cancer. 2024;24:1407. PubMedAbstract available
WEI GX, Zhou YW, Dong C, Zhang T, et al Clinicopathologic features and treatment efficacy of patients with BRAF
V600E-mutated metastatic colorectal cancer: a multi-center real-world propensity
score matching study.
BMC Cancer. 2024;24:1395. PubMedAbstract available
CUI F, Chen Y, Wu X, Zhao W, et al Mesenchymal stem cell-derived exosomes carrying miR-486-5p inhibit glycolysis and
cell stemness in colorectal cancer by targeting NEK2.
BMC Cancer. 2024;24:1356. PubMedAbstract available
October 2024
LIU S, Teng F, Lu Y, Zhu Y, et al Ethoxy-erianin phosphate inhibits angiogenesis in colorectal cancer by regulating
the TMPO-AS1/miR-126-3p/PIK3R2 axis and inactivating the PI3k/AKT signaling
pathway.
BMC Cancer. 2024;24:1275. PubMedAbstract available
NZITAKERA A, Uwamariya D, Kato H, Surwumwe JB, et al TP53 mutation status and consensus molecular subtypes of colorectal cancer in
patients from Rwanda.
BMC Cancer. 2024;24:1266. PubMedAbstract available
RASCHZOK N, Moosburner S, Blank M, Krenzien F, et al Is interval chemotherapy safe and does it improve the outcome of patients with
colorectal liver metastases undergoing multimodal two-stage hepatectomy? - A
systematic literature review.
BMC Cancer. 2024;24:1260. PubMedAbstract available
BRENNE SS, Madsen PH, Pedersen IS, Hveem K, et al The prognostic role of circulating tumour DNA detected prior to clinical
diagnosis of colorectal cancer in the HUNT study.
BMC Cancer. 2024;24:1251. PubMedAbstract available
GUO T, Liu K, Guo Y, Zhang H, et al CapeOX as neoadjuvant chemotherapy for locally advanced rectal cancer: might less
be more?
BMC Cancer. 2024;24:1248. PubMedAbstract available
CAI C, Zhang X, Sun X, Wang H, et al Node-sparing modified short-course Radiotherapy Combined with CAPOX and
Tislelizumab for locally Advanced MSS of Middle and low rectal Cancer (mRCAT): an
open-label, single-arm, prospective, multicentre clinical trial.
BMC Cancer. 2024;24:1247. PubMedAbstract available
GUO T, Cheng B, Li Y, Li Y, et al A radiomics model for predicting perineural invasion in stage II-III colon cancer
based on computer tomography.
BMC Cancer. 2024;24:1226. PubMedAbstract available
September 2024
LIU Y, Ming H, Xu L, Li L, et al DNA methylation analysis of the SDC2, SEPT9 and VIM genes in fecal DNA for
colorectal cancer diagnosis.
BMC Cancer. 2024;24:1205. PubMedAbstract available
ZHOU J, Cui M, Liang J, Zhao J, et al ZYG11B participates in the modulation of colorectal cancer cell proliferation and
immune infiltration and is a prognostic biomarker.
BMC Cancer. 2024;24:1203. PubMedAbstract available
WISMAYER R, Matthews R, Whalley C, Kiwanuka J, et al Determination of the frequency and distribution of APC, PIK3CA, and SMAD4 gene
mutations in Ugandan patients with colorectal cancer.
BMC Cancer. 2024;24:1212. PubMedAbstract available
ZHU Z, Li J, Fa Z, Xu X, et al Functional gene signature offers a powerful tool for characterizing
clinicopathological features and depicting tumor immune microenvironment of
colorectal cancer.
BMC Cancer. 2024;24:1199. PubMedAbstract available
MATHUR A, Bareja C, Mittal M, Singh A, et al Targeting cellular plasticity: esculetin-driven reversion of stem cell-like
characteristics and EMT phenotype in transforming cells with sequential p53/p73
knockdowns.
BMC Cancer. 2024;24:1164. PubMedAbstract available
HASSAN S, Mirza T, Khatoon A, Bukhari U, et al BRAF mutations and the association of V600E with CD133 and CDX2 expression in a
Pakistani colorectal carcinoma cohort.
BMC Cancer. 2024;24:1162. PubMedAbstract available
WANG X, Wang H, He H, Lv K, et al Clinicopathological and prognostic features of colorectal mucinous
adenocarcinomas: a systematic review and meta-analysis.
BMC Cancer. 2024;24:1161. PubMedAbstract available
TANG Y, Fan Y Combined KRAS and TP53 mutation in patients with colorectal cancer enhance
chemoresistance to promote postoperative recurrence and metastasis.
BMC Cancer. 2024;24:1155. PubMedAbstract available
HOANG T, Cho S, Choi JY, Kang D, et al Genetically predicted dietary intake and risks of colorectal cancer: a Mendelian
randomisation study.
BMC Cancer. 2024;24:1153. PubMedAbstract available
ZHU J, Zhi S, Zeng J, Zhou S, et al Development and validation of a TRIM27-based nomogram for predicting metachronous
liver metastasis and prognosis in postoperative colorectal cancer patients.
BMC Cancer. 2024;24:1142. PubMedAbstract available
DENG W, Xiong X, Lu M, Huang S, et al Curcumin suppresses colorectal tumorigenesis through restoring the gut microbiota
and metabolites.
BMC Cancer. 2024;24:1141. PubMedAbstract available
GAMAGE BD, Ranasinghe D, Sahankumari A, Malavige GN, et al Metagenomic analysis of colonic tissue and stool microbiome in patients with
colorectal cancer in a South Asian population.
BMC Cancer. 2024;24:1124. PubMedAbstract available
ZHANG W, Hou Z, Zhang L, Hong X, et al A log odds of positive lymph nodes-based predictive model effectively forecasts
prognosis and guides postoperative adjuvant chemotherapy duration in stage III
colon cancer: a multi-center retrospective cohort study.
BMC Cancer. 2024;24:1088. PubMedAbstract available
CHENG Y, Teng Z, Zhang Y, Jin B, et al Irinotecan plus raltitrexed as second-line treatment in locally advanced or
metastatic colorectal cancer patients: a prospective open-label, single-arm,
multi-center, phase II study.
BMC Cancer. 2024;24:1082. PubMedAbstract available
OUYANG Z, Chen P, Zhang M, Wu S, et al Arginine on immune function and post-operative obstructions in colorectal cancer
patients: a meta-analysis.
BMC Cancer. 2024;24:1089. PubMedAbstract available
August 2024
TONGOL E, Kang P, Cheng V, Gastonguay L, et al What are the experiences of colorectal cancer patients with biomarker testing in
Canada?: a mixed methods study.
BMC Cancer. 2024;24:1076. PubMedAbstract available
WANG Y, Wei Y, Huang J, Li X, et al Prognostic value of matrix metalloproteinase-2 protein and matrix
metalloproteinase-9 protein in colorectal cancer: a meta-analysis.
BMC Cancer. 2024;24:1065. PubMedAbstract available
FENG Y, Wang K, Fan J, Wu X, et al Mindfulness intervention, homogeneous medical concept, and concentrated solution
nursing for colorectal cancer patients: a retrospective study.
BMC Cancer. 2024;24:1055. PubMedAbstract available
NOBIN H, Garvin S, Hagman H, Nodin B, et al The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected
colorectal cancer without neoadjuvant therapy - differences between antibody
clones and cell types.
BMC Cancer. 2024;24:1051. PubMedAbstract available
CAI W, Li Z, Liu B, Cao Y, et al A predictive model for colorectal cancer complicated with intestinal obstruction
based on specific inflammation score.
BMC Cancer. 2024;24:1035. PubMedAbstract available
KUSUNOKI C, Uemura M, Osaki M, Takiguchi N, et al Postoperative venous thromboembolism after surgery for locally recurrent rectal
cancer.
BMC Cancer. 2024;24:1027. PubMedAbstract available
HAGHI NAVAND A, Jalilian S, Ahmadi Angali K, Karimi Babaahmadi M, et al A new evaluation of the rearranged non-coding control region of JC virus in
patients with colorectal cancer.
BMC Cancer. 2024;24:1001. PubMedAbstract available
MA Y, Zhang J, Wei C, Wang F, et al Identification and experimental verification of a biomarker by combining the
unfolded protein response with the immune cells in colon cancer.
BMC Cancer. 2024;24:978. PubMedAbstract available
LI X, Chen Y, Liang Y, Shi W, et al 5-Fluorouracil resistance due to sphingosine kinase 2 overexpression in
colorectal cancer is associated with myeloid-derived suppressor cell-mediated
immunosuppressive effects.
BMC Cancer. 2024;24:983. PubMedAbstract available
ZENG X, Li C, Yu M, Zhang R, et al Laparoscopic versus open surgery for rectal neuroendocrine tumors: a multicenter
real-world study.
BMC Cancer. 2024;24:956. PubMedAbstract available
BEKAII-SAAB T, Khan N, Ostojic H, Jiao X, et al Real-world dosing of regorafenib and outcomes among patients with metastatic
colorectal cancer: a retrospective analysis using US claims data.
BMC Cancer. 2024;24:939. PubMedAbstract available
July 2024
CHU S, Ren X, Cao L, Ma C, et al HOXC11-mediated regulation of mitochondrial function modulates chemoresistance in
colorectal cancer.
BMC Cancer. 2024;24:921. PubMedAbstract available
WU Y, Tong Y, Zhang H, Li Y, et al A novel dual-target Septin9 methylation assay for improved detection of
early-stage colorectal cancer and high-grade intraepithelial neoplasia.
BMC Cancer. 2024;24:916. PubMedAbstract available
SUN Q, Long L Diagnostic performances of methylated septin9 gene, CEA, CA19-9 and
platelet-to-lymphocyte ratio in colorectal cancer.
BMC Cancer. 2024;24:906. PubMedAbstract available
ALVAREZ JA, Shi Q, Dasari A, Garcia-Aguilar J, et al Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase
II/III trial testing the efficacy of triplet versus doublet chemotherapy
regarding clinical complete response and disease-free survival in patients with
locally advanced rec
BMC Cancer. 2024;24:901. PubMedAbstract available
ZHAN Y, Cheng X, Mei P, Tan S, et al Safety of first-line systemic therapy in patients with metastatic colorectal
cancer: a network meta-analysis of randomized controlled trials.
BMC Cancer. 2024;24:893. PubMedAbstract available
KARTHAUS M, Heinemann V, Riera-Knorrenschild J, Kretzschmar A, et al Subgroup analyses from patients with pre-treated metastatic colorectal cancer
receiving trifluridine/tipiracil: results of the TALLISUR trial.
BMC Cancer. 2024;24:887. PubMedAbstract available
SUE-CHUE-LAM C, Brezden-Masley C, Sutradhar R, Yu AYX, et al Association of oxaliplatin-containing adjuvant duration with post-treatment
fall-related injury and fracture in patients with stage III colon cancer: a
population-based retrospective cohort study.
BMC Cancer. 2024;24:878. PubMedAbstract available
TANG C, He F, Yang F, Chen D, et al Development and validation of a nomogram for preoperatively predicting permanent
stoma after rectal cancer surgery with ileostomy: a retrospective cohort study.
BMC Cancer. 2024;24:874. PubMedAbstract available
YANG J, Ding X, Fang Z, Wu S, et al Association of CD8(+)TILs co-expressing granzyme A and interferon-gamma with colon
cancer cells in the tumor microenvironment.
BMC Cancer. 2024;24:869. PubMedAbstract available
LI A, Gao H, Wu H, Xie Y, et al Genetic association and functional implications of TLR4 rs1927914 polymorphism on
colon cancer risk.
BMC Cancer. 2024;24:858. PubMedAbstract available
MIAO X, Wang F, Yunus MA, Ismail IS, et al Long noncoding RNA KCNMA1-AS2 regulates the function of colorectal cancer cells
and sponges miR-1227-5p.
BMC Cancer. 2024;24:857. PubMedAbstract available
BINIAZ M, Moradi A, Basit MG, Pashaki AS, et al Combination of neoadjuvant and adjuvant chemotherapy with FOLFOX compared with
adjuvant chemotherapy in management of locally advanced rectal cancers: a
randomized trial of a promising therapeutic approach.
BMC Cancer. 2024;24:863. PubMedAbstract available
LI X, Wu X, Chen C, Chao H, et al A randomized controlled trial of a self-led, virtual reality-based cognitive
behavioral therapy on sick role adaptation in colorectal cancer patients: study
protocol.
BMC Cancer. 2024;24:847. PubMedAbstract available
LI Y, Hu G, Zhang J, Qiu W, et al Nomogram for predicting the probability of rectal anastomotic re-leakage after
stoma closure: a retrospective study.
BMC Cancer. 2024;24:834. PubMedAbstract available
MATBOLI M, Hossam N, Farag D, Hassan M, et al miRNAs: possible regulators of toll like receptors and inflammatory tumor
microenvironment in colorectal cancer.
BMC Cancer. 2024;24:824. PubMedAbstract available
AYNALEM ZB, Adal AB, Ayele TF, Bayeh GM, et al Mortality rate and predictors of colorectal cancer patients in Ethiopia: a
systematic review and meta-analysis.
BMC Cancer. 2024;24:821. PubMedAbstract available
TALBOT A, Jebb SA, Foster C, Realpe AX, et al Participants' perspectives of being recruited into a randomised trial of a weight
loss intervention before colorectal cancer surgery: a qualitative interview
study.
BMC Cancer. 2024;24:802. PubMedAbstract available
June 2024
LIU X, Wang Y, Wang W, Dong H, et al The association between systemic immune-inflammation index and cardiotoxicity
related to 5-Fluorouracil in colorectal cancer.
BMC Cancer. 2024;24:782. PubMedAbstract available
XU J, Pan L, Wu D, Yao L, et al Comparison of the diagnostic value of various microRNAs in blood for colorectal
cancer: a systematic review and network meta-analysis.
BMC Cancer. 2024;24:770. PubMedAbstract available
XU M, Chen Y, Li P, Ye Q, et al Antibiotic use during radical surgery in stage I-III colorectal cancer:
correlation with outcomes?
BMC Cancer. 2024;24:769. PubMedAbstract available
LI A, Li Q, Wang C, Bao X, et al Constructing a prognostic model for colon cancer: insights from immunity-related
genes.
BMC Cancer. 2024;24:758. PubMedAbstract available
HUANG R, Jin X, Jiang Z, Wang Y, et al Genetically evaluating the causal role of peripheral immune cells in colorectal
cancer: a two-sample Mendelian randomization study.
BMC Cancer. 2024;24:753. PubMedAbstract available
TAKAHASHI M, Sakamoto K, Kogure Y, Nojiri S, et al Use of 3D-CT-derived psoas major muscle volume in defining sarcopenia in
colorectal cancer.
BMC Cancer. 2024;24:741. PubMedAbstract available
LIU Q, Wang H, Chen Q, Luo R, et al Nomogram incorporating preoperative pan-immune-inflammation value and monocyte to
high-density lipoprotein ratio for survival prediction in patients with
colorectal cancer: a retrospective study.
BMC Cancer. 2024;24:740. PubMedAbstract available
HOU C, Liu J, Liu J, Yao D, et al METTL3-induced circ_0008345 contributes to the progression of colorectal cancer
via the microRNA-182-5p/CYP1A2 pathway.
BMC Cancer. 2024;24:728. PubMedAbstract available
NIU Y, Wen L, Yang Y, Zhang Y, et al Diagnostic performance of Node Reporting and Data System (Node-RADS) for
assessing mesorectal lymph node in rectal cancer by CT.
BMC Cancer. 2024;24:716. PubMedAbstract available
ZHAN ZQ, Huang ZM, Lan QW, Luo YH, et al Integrated multi-omics analyses revealed the association between rheumatoid
arthritis and colorectal cancer: MYO9A as a shared gene signature and an
immune-related therapeutic target.
BMC Cancer. 2024;24:714. PubMedAbstract available
BIYU H, Mengshan L, Yuxin H, Ming Z, et al A miRNA-disease association prediction model based on tree-path global feature
extraction and fully connected artificial neural network with multi-head
self-attention mechanism.
BMC Cancer. 2024;24:683. PubMedAbstract available
YE J, Ying J, Chen H, Wu Z, et al PPIH acts as a potential predictive biomarker for patients with common solid
tumors.
BMC Cancer. 2024;24:681. PubMedAbstract available
AQUINO DE MORAES FC, Dantas Leite Pessoa FD, Duarte de Castro Ribeiro CH, Rodrigues Fernandes M, et al Trifluridine-tipiracil plus bevacizumab versus trifluridine-tipiracil monotherapy
for chemorefractory metastatic colorectal cancer: a systematic review and
meta-analysis.
BMC Cancer. 2024;24:674. PubMedAbstract available
LI KZ, Liao XM, Li SQ, Wei HT, et al Identification and diagnostic potential of hsa_circ_101303 in colorectal cancer:
unraveling a regulatory network.
BMC Cancer. 2024;24:671. PubMedAbstract available
May 2024
YOSHIMOTO T, Nishi M, Okikawa S, Yoshikawa K, et al Blue light irradiation inhibits the M2 polarization of the cancer-associated
macrophages in colon cancer.
BMC Cancer. 2024;24:664. PubMedAbstract available
WANG X, Guan X, Tong Y, Liang Y, et al UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers
for Colorectal Cancer.
BMC Cancer. 2024;24:644. PubMedAbstract available
SHI X, Zhao X, Xue J, Jia E, et al Extracellular vesicle biomarkers in circulation for colorectal cancer detection:
a systematic review and meta-analysis.
BMC Cancer. 2024;24:623. PubMedAbstract available
WANG JY, Zhang XP, Zhou HK, Cai HX, et al The selective sponging of miRNAs by OIP5-AS1 regulates metabolic reprogramming of
pyruvate in adenoma-carcinoma transition of human colorectal cancer.
BMC Cancer. 2024;24:611. PubMedAbstract available
ELSHAMI M, Dwikat MF, Al-Slaibi I, Alser M, et al Understanding the interplay of colorectal cancer awareness and attitudes among
Palestinians: a national cross-sectional study.
BMC Cancer. 2024;24:590. PubMedAbstract available
SLANINOVA V, Heron-Milhavet L, Robin M, Jeanson L, et al The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in
p53 proficient colon cancer cells.
BMC Cancer. 2024;24:587. PubMedAbstract available
ZHANG H, Li X, Sun W, Qin H, et al PTEN and P-4E-BP1 might be associated with postoperative recurrence of rectal
cancer patients undergoing concurrent radiochemotherapy.
BMC Cancer. 2024;24:582. PubMedAbstract available
CAI J, Yang Y, Zhang L, Fang Y, et al Investigation of ENO2 as a promising novel marker for the progression of
colorectal cancer with microsatellite instability-high.
BMC Cancer. 2024;24:573. PubMedAbstract available
SUN L, Wang J, Li Y, Kang Y, et al Correlation of gasdermin B staining patterns with prognosis, progression, and
immune response in colorectal cancer.
BMC Cancer. 2024;24:567. PubMedAbstract available
April 2024
CUNNINGHAM R, Stanley J, Imlach F, Haitana T, et al Cancer diagnosis after emergency presentations in people with mental health and
substance use conditions: a national cohort study.
BMC Cancer. 2024;24:546. PubMedAbstract available
RAO L, Xu P, Zhang G, Zu R, et al Prognostic value of creatine kinase (CK)-MB to total-CK ratio in colorectal
cancer patients after curative resection.
BMC Cancer. 2024;24:543. PubMedAbstract available
WU Y, Chen C, Hua X, Zhao C, et al Association of the TRIM family protein with survival outcomes and
clinicopathological features in colorectal cancer: a systematic review and
meta-analysis.
BMC Cancer. 2024;24:537. PubMedAbstract available
ALSADHAN N, Alhurishi SA, Pujades-Rodriguez M, Shuweihdi F, et al Demographic and clinical characteristics associated with advanced stage
colorectal cancer: a registry-based cohort study in Saudi Arabia.
BMC Cancer. 2024;24:533. PubMedAbstract available
HU S, Xiao Q, Gao R, Qin J, et al Identification of BGN positive fibroblasts as a driving factor for colorectal
cancer and development of its related prognostic model combined with machine
learning.
BMC Cancer. 2024;24:516. PubMedAbstract available
LIU H, Xu H, Liu Y, Zhao Y, et al Comparative characteristics of early-onset vs. late-onset advanced colorectal
cancer: a nationwide study in China.
BMC Cancer. 2024;24:503. PubMedAbstract available
XU T, Feng L, Zhang W, Li H, et al The efficacy and safety of short-course radiotherapy followed by sequential
chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a
phase II study.
BMC Cancer. 2024;24:501. PubMedAbstract available
SOOMRO MY, Khan SR, Muhammad H, Ahmad S, et al Exploring treatment outcomes in Stage II-III rectal cancer patients undergoing
neoadjuvant therapy at a tertiary care center in Pakistan: a comprehensive
analysis of pathological outcomes.
BMC Cancer. 2024;24:479. PubMedAbstract available
LI Y, Chen Z, Tian S, Han X, et al Stereotactic ablative brachytherapy versus percutaneous microwave ablation as
salvage treatments for lung oligometastasis from colorectal cancer.
BMC Cancer. 2024;24:481. PubMedAbstract available
WADDELL O, Pearson J, McCombie A, Marshall H, et al The incidence of early onset colorectal cancer in Aotearoa New Zealand:
2000-2020.
BMC Cancer. 2024;24:456. PubMedAbstract available
ELEZ E, Cubillo A, Alfonso PG, Middleton MR, et al Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients
with previously treated microsatellite-stable metastatic colorectal cancer with
RAS mutations in an open-label phase 1b/2 study.
BMC Cancer. 2024;24:446. PubMedAbstract available
HUANG Y, Chen D, Bai Y, Zhang Y, et al ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental
validation.
BMC Cancer. 2024;24:452. PubMedAbstract available
CHEN H, Wang C, Chen Z, Huang T, et al The depth of perineural invasion is an independent prognostic factor for stage II
colorectal cancer.
BMC Cancer. 2024;24:433. PubMedAbstract available
TIAN Y, Wang Y, Wen N, Wang S, et al Prognostic factors associated with early recurrence following liver resection for
colorectal liver metastases: a systematic review and meta-analysis.
BMC Cancer. 2024;24:426. PubMedAbstract available
XIAO Y, Wen X, Ying Y, Zhang X, et al Correlation between spleen density and prognostic outcomes in patients with
colorectal cancer after curative resection.
BMC Cancer. 2024;24:425. PubMedAbstract available
GHOFRANI-SHAHPAR M, Pakravan K, Razmara E, Amooie F, et al Cancer-associated fibroblasts drive colorectal cancer cell progression through
exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6
production.
BMC Cancer. 2024;24:400. PubMedAbstract available
March 2024
LEE KH, Yang IJ, Ha GW, Lee J, et al mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon
cancer - the FROST trial: study protocol for a multicenter, randomized
controlled, phase II trial.
BMC Cancer. 2024;24:397. PubMedAbstract available
MAHDI-ESFERIZI R, Shiasi Z, Heidari R, Najafi A, et al Single-cell transcriptional signature-based drug repurposing and in vitro
evaluation in colorectal cancer.
BMC Cancer. 2024;24:371. PubMedAbstract available
STORM KS, Astrom LM, Sibolt P, Behrens CP, et al ROAR-A: re-optimization based Online Adaptive Radiotherapy of anal cancer, a
prospective phase II trial protocol.
BMC Cancer. 2024;24:374. PubMedAbstract available
DING H, Lin J, Xu Z, Wang HHX, et al The association between organised colorectal cancer screening strategies and
reduction of its related mortality: a systematic review and meta-analysis.
BMC Cancer. 2024;24:365. PubMedAbstract available
LIN T, Zhang S, Tang Y, Xiao M, et al ART1 knockdown decreases the IL-6-induced proliferation of colorectal cancer
cells.
BMC Cancer. 2024;24:354. PubMedAbstract available
MATHUR S, Srivastava P, Srivastava A, Rai NK, et al Regulation of metastatic potential by drug repurposing and mitochondrial
targeting in colorectal cancer cells.
BMC Cancer. 2024;24:323. PubMedAbstract available
XIA S, Li Q, Zhu HT, Zhang XY, et al Fully semantic segmentation for rectal cancer based on post-nCRT MRl modality and
deep learning framework.
BMC Cancer. 2024;24:315. PubMedAbstract available
DUAN J, Zhu L, Shi Y, Wang W, et al Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line
treatment of patients with metastatic colorectal cancer: a real-world cohort
study.
BMC Cancer. 2024;24:302. PubMedAbstract available
HUANG JX, Zhang X, Tang M, Zhang Q, et al Comprehensive evaluation of serum hepatic proteins in predicting prognosis among
cancer patients with cachexia: an observational cohort study.
BMC Cancer. 2024;24:293. PubMedAbstract available
February 2024
SONG M, Zhou X, Hou R, Sigdel M, et al CT-guided radioactive (125)I seeds brachytherapy for lung oligometastases from
colorectal cancer: initial results.
BMC Cancer. 2024;24:265. PubMedAbstract available
LIU Y, Hu X, Huang Y, Yin X, et al Does transanal drainage tubes placement have an impact on the incidence of
anastomotic leakage after rectal cancer surgery? a systematic review and
meta-analysis.
BMC Cancer. 2024;24:263. PubMedAbstract available